The Motley Fool

Stock market crash: I’d invest £10k in these 2 UK shares in an ISA today to make a million

Our message here at The Motley Fool is clear… stock market crashes happen, sure. But those investors who build a well-balanced portfolio of quality shares should still expect to make exceptional returns.

It can be an easy thing to forget when stock prices are going to hell in a handcart. Those that remember, though, and buy equities following a stock market crash tend to be the ones who are most successful. They benefit from buying quality at rock-bottom prices and then watching their investments rocket in value as economic conditions improve.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

I think many UK shares look too good to miss following the 2020 financial market meltdown. And even though another stock market crash might be brewing, I’d buy them today in an ISA in expectation of exceptional long-term gains.

Financial technology concept. Stock market crash.

I’d buy this bank after the crash

I’d very happily buy TBC Bank Group (LSE: TBCG) after the 2020 market crash. This most cyclical of shares stands to take a big profits hit because of Covid-19. Thankfully, though, infection rates in Georgia have been modest (just over 1,000 at the last count). And this should help the Eurasian country’s economy rebound relatively quickly.

The Asian Development Bank expects Georgia’s GDP to rebound 5% in 2021 following a 5% drop this year. Retail banking giant TBC Bank is well placed to ride this bounceback, of course. I expect profits here to continue rocketing through the rest of the 2020s, too as wealth levels in the nation grow and the FTSE 250 firm’s huge investments in digital banking and international expansion pay off.

Following the stock market crash TBC Bank trades on a forward price-to-earnings (P/E) ratio of 7 times. Given its superior long-term profits outlook — and particularly compared with embattled British banks like Lloyds — I reckon this UK share is a steal.

Medical marvel

Another brilliant bargain I’d buy right now is GlaxoSmithKline (LSE: GSK). The stock market crash leaves it trading on a P/E ratio of just 13 times for 2020. The pharmaceuticals giant carries an enormous dividend yield north of 5%, too.

In my opinion Glaxo’s one of the most oversold stocks on the FTSE 100 today. The essential nature of its products means that profits growth should remain robust this year and next, irrespective of Covid-19. I’d buy it today because of its exceptional long-term outlook, built upon rampant population growth and rising healthcare investment all over the world.

The IQVIA Institute for Human Data Science reckons global medicine demand could grow at a compound annual growth rate of 6% through to 2023. And it says that new products launched over the next few years will command a higher level of spending. This bodes well for Glaxo, which has more than 30 new medicines in development.

Buying Glaxo and TBC Bank shares at today’s prices leaves plenty of scope for investors to enjoy big gains in the years ahead. But they’re not the only cut-price powerhouses worthy of serious attention today. With a little bit of research it’s possible to build a formidable shares portfolio for next to nothing. And I for one plan to continue buying for my ISA following the market crash.

A Top Share with Enormous Growth Potential

Savvy investors like you won’t want to miss out on this timely opportunity…

Here’s your chance to discover exactly what has got our Motley Fool UK analyst all fired up about this ‘pure-play’ online business (yes, despite the pandemic!).

Not only does this company enjoy a dominant market-leading position…

But its capital-light, highly scalable business model has previously helped it deliver consistently high sales, astounding near-70% margins, and rising shareholder returns … in fact, in 2019 it returned a whopping £150m+ to shareholders in dividends and buybacks!

And here’s the really exciting part…

While COVID-19 may have thrown the company a curveball, management have acted swiftly to ensure this business is as well placed as it can be to ride out the current period of uncertainty… in fact, our analyst believes it should come roaring back to life, just as soon as normal economic activity resumes.

That’s why we think now could be the perfect time for you to start building your own stake in this exceptional business – especially given the shares look to be trading on a fairly undemanding valuation for the year to March 2021.

Click here to claim your copy of this special report now — and we’ll tell you the name of this Top Growth Share… free of charge!

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.